DE NOVELLIS, DANILO
 Distribuzione geografica
Continente #
EU - Europa 314
AS - Asia 125
NA - Nord America 78
SA - Sud America 17
Totale 534
Nazione #
DE - Germania 109
RU - Federazione Russa 84
SG - Singapore 83
US - Stati Uniti d'America 78
FI - Finlandia 54
IT - Italia 43
BR - Brasile 17
IN - India 15
CN - Cina 14
AT - Austria 11
CZ - Repubblica Ceca 9
HK - Hong Kong 7
TR - Turchia 4
IE - Irlanda 3
JP - Giappone 1
NL - Olanda 1
UZ - Uzbekistan 1
Totale 534
Città #
Munich 95
Helsinki 43
Singapore 30
Ashburn 23
Nuremberg 14
Moscow 11
Brno 9
Rome 9
Hong Kong 7
Milan 7
Beijing 5
Jyväskylä 5
Salerno 5
Los Angeles 4
Vienna 4
Boardman 3
Dublin 3
Fort Worth 3
Lappeenranta 3
Mumbai 3
Nellore 3
Piacenza 3
Seattle 3
Bologna 2
Chennai 2
Krasnodar 2
Muğla 2
Santa Clara 2
St Petersburg 2
Turin 2
Ankara 1
Belo Horizonte 1
Brasília 1
Camaquã 1
Catania 1
Council Bluffs 1
Curitiba 1
Dallas 1
Divinópolis 1
Ibitirama 1
Inhumas 1
Istanbul 1
Jinan 1
Jinhua 1
Juiz de Fora 1
Nova Friburgo 1
Presidente Prudente 1
Prineville 1
Quirinópolis 1
Ribeirão das Neves 1
Rio de Janeiro 1
Shaoxing 1
Sumaré 1
São Leopoldo 1
São Paulo 1
Tashkent 1
Tokyo 1
Tucano 1
Villaverla 1
Washington 1
Yekaterinburg 1
Yubileyny 1
Zhengzhou 1
Totale 342
Nome #
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 167
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 34
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies 31
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 31
A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A 27
SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER OF MULTIPLE MYELOMA PROGRESSION AND ASSOCIATED RENAL DISEASE 27
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 26
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience 26
Multiple myeloma characteristics correlated to serum free light chain ratio at diagnosis and association with early renal damage 23
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients 21
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients 21
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients 21
Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition 19
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience 18
Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience 17
Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review 16
Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance 15
Efficacy of Daratumumab-Based Regimens for Extramedullary Pulmonary Plasmacytoma: A Case Report 14
Totale 554
Categoria #
all - tutte 3.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.054


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202315 0 0 0 0 1 3 5 1 2 0 3 0
2023/2024114 11 10 9 9 6 16 6 4 3 4 15 21
2024/2025425 17 11 9 14 26 50 137 50 88 22 1 0
Totale 554